Cashing In: Ebola virus becomes brand name
World Health Organization says it hopes to test two new Ebola vaccines in West Africa by January. They will be given to twenty thousand front line health care workers to begin with. And while the epidemic could be a lucrative market for drug companies others are already cashing in. Gayane Chichakyan investigates.
[youtube height=”326″ width=”580″]https://www.youtube.com/watch?v=4Asb66FQb1M&list=UUpwvZwUam-URkxB7g4USKpg[/youtube]